Getting the Gist Across Is Enough for Informed Consent for Acute Stroke Thrombolytics

Stroke. 2019 Jun;50(6):1595-1597. doi: 10.1161/STROKEAHA.119.024653. Epub 2019 May 14.

Authors

Lesli E Skolarus^{1

2}, Alison O'Brien^{1

2}, William J Meurer^{1

3}, Brian J Zikmund Fisher²

Affiliations

¹ From the Stroke Program (L.E.S., A.O., W.J.M.) Medicine, University of Michigan Medical School, Ann Arbor.
² Department of Health Behavior of Health Education, University of Michigan School of Public Health, Ann Arbor (L.E.S., A.O., B.J.Z.F.).
³ Department of Emergency (W.J.M.) Medicine, University of Michigan Medical School, Ann Arbor.

No abstract available

Keywords: decision-making; emergency medicine; informed consent; neurology; risk; tissue-type plasminogen activator.

Publication types

Editorial
Research Support, N.I.H., Extramural

MeSH terms

Fibrinolytic Agents / therapeutic use*
Humans
Informed Consent*
Stroke / drug therapy*

Substances

Fibrinolytic Agents

Grants and funding

U01 MD010579/MD/NIMHD NIH HHS/United States